neurology
Teva bolsters neurology unit through Auspex deal
March 31, 2015Sales and Marketing CNS, SD-809, Teva, Tourette syndrome, auspex, deutetrabenazine, neurology
Teva is significantly enhancing its neurology business by acquiring US biopharma firm Auspex in a deal worth $3.5 billion. Teva …
Biogen signs neurology deal
September 11, 2013Research and Development, Sales and Marketing Biogen IDEC, Isis, antisense, neurology
Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …
Ipsen buys Syntaxin
July 16, 2013Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi
French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Latest content
Scots neonatal innovations target hearing loss and earlier care
August 28, 2026
Agentis Health Group acquires Clinical Pharmacist Solutions
August 26, 2026
